Chao, Ta-Chung <br/><br/>
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial.  [electronic resource] 

 -  Investigational new drugs  Mar 2005 
 - 171-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1007/s10637-005-5863-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Chemistry, Pharmaceutical<br/>Humans<br/>Infusions, Intravenous<br/>Middle Aged<br/>Paclitaxel--adverse effects